AI technology developer Blackford has entered into a partnership with Quibim to integrate Quibim’s AI-based diagnostic QP-Prostate software into the Blackford Platform.
Under the agreement, QP-Prostate will be available on Blackford’s platform, which provides healthcare providers with access to a portfolio of more than 140 AI-driven programs designed to improve workflows and diagnostic accuracy, the firms said in a statement.
QP-Prostate, which is CE-marked as a class IIB device, automatically evaluates image quality, segmenting the prostate gland and identifying suspicious lesions to support radiologists in making more efficient and accurate diagnoses, according to the Valencia-based Quibim.
